RxDoctor Payments Data

Michael McCollum, MD

Gynecologic Oncology · Norfolk, VANPI 1306815287

Payments from drug & device makers

What this record shows

That places this record below the midpoint for gynecologic oncology clinicians in VA, where the typical reported total is $1,719.

No general payments reported

No drug or device maker reported general payments to this provider for 2019–2025. That is a common and unremarkable result.

$848,099in research payments, 2019–2025

Across 120 payments — averaging $7067.49 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Pfizer$425K
  • GSK$283K
  • Genmab U.S., Inc.$74K
  • Genentech, Inc.$48K
  • AstraZeneca$15K
  • Seagen Inc.$2K
  • plus $1K from 1 others

How this compares

$0 in reported general payments places this provider in the 0th percentile of 47 gynecologic oncology providers in Virginia.

See all gynecologic oncology providers in Virginia

Medicare billing

Part B allowed, 2024
$1,805,733
Medicare patients
309
Services billed
111,516

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Dexamethasone87$719
Prochlorperazine Maleate29$410
Lidocaine Hcl23$312
Ondansetron OdtOndansetron18$238
Lidocaine-PrilocaineLidocaine/Prilocaine17$195
Levothyroxine Sodium19$147

Paid to pharmacies, not to this prescriber.

Other gynecologic oncology in Norfolk

See the full list for Virginia

Where these figures come from

Is this you, or does something look wrong? →